Hydromer, Inc., a leader in hydrophilic, thromboresistant and antimicrobial coating technologies, has announced its expansion into the manufacturing and global supply of UV coating, curing and testing equipment. This strategic move allows the company to provide medical device manufacturers with a comprehensive, end-to-end solution that integrates proprietary coatings with high-performance machinery.
The integrated platform enables manufacturers to correlate process parameters directly with performance outcomes, supporting compliance with ISO 13485 and FDA Quality System Regulations (21 CFR Part 820). By controlling both the coating formulations and the application equipment, Hydromer aims to eliminate technical barriers that often delay product development cycles in the highly regulated medical device sector.
The company's expanded equipment platform includes several key systems designed to enhance manufacturing efficiency. The Hydrophilic Coating Equipment delivers uniform coating application and UV curing with minimal manual intervention. The Automated High-Throughput Coating System features a modular design with load, dip coating and UV curing workstations that can be operated by a single operator, increasing production rates while reducing reliance on manual labor. Additionally, the Friction Testing Equipment provides precise and repeatable measurements for lubricity tests, supporting performance evaluation and quality control protocols.
"Hydromer has long been focused on coating performance and manufacturing consistency," said Michael Torti, CEO of Hydromer. "By manufacturing and supplying the equipment used to apply our industry-leading hydrophilic coatings, we eliminate technical barriers and help our clients reduce time to market while maintaining the highest standards of quality and regulatory confidence."
This expansion represents a significant shift in Hydromer's business model, transforming the company from a coating solutions provider to a comprehensive manufacturing partner. For medical device companies, this integration could streamline the production process by ensuring compatibility between coatings and application equipment, potentially reducing validation time and costs associated with bringing new devices to market. The move also positions Hydromer to capture more value within the medical device supply chain by offering bundled solutions rather than individual components.
The timing of this expansion coincides with increasing regulatory scrutiny and quality requirements in the medical device industry globally. By offering equipment that supports compliance with international standards, Hydromer addresses a critical pain point for manufacturers operating in multiple jurisdictions. The company's decades of experience in coating technologies, combined with its new equipment manufacturing capabilities, creates a unique value proposition in a market where precision, consistency and regulatory compliance are paramount.
For business and technology leaders in the medical device sector, Hydromer's expansion signals a trend toward vertical integration among specialty suppliers. This approach could potentially reduce supply chain complexity and improve quality control by minimizing the number of vendors involved in critical manufacturing processes. As medical devices become increasingly sophisticated and regulatory requirements more stringent, integrated solutions like Hydromer's may become more attractive to manufacturers seeking to optimize their production systems while maintaining compliance.
